Antimicrobial therapy for erysipelas in hemodynamically stable children older than 28 days

This algorithm is meant to be used with UpToDate content on the evaluation and management of suspected Staphylococcus aureus or streptococcal SSTIs in children. Refer to UpToDate content for additional details, including management of hemodynamically unstable patients, doses of antibiotics, and alternative agents for children who cannot take penicillins and/or cephalosporins.

GAS: group A Streptococcus; SSTI: skin and soft tissue infection; IV: intravenous.
* The first 1 or 2 doses of parenteral therapy may be provided in an emergency department observation or "short stay" unit if one is available.
¶ The diameter of the lesion includes surrounding erythema.

Prepared with data from:

American Academy of Pediatrics. Staphylococcus aureus. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32^nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.678.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:147.

Graphic 131685 Version 1.0

خرید پکیج

Antimicrobial therapy for erysipelas in hemodynamically stable children older than 28 days